IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

Cell

Volumn 131, Issue 4, 2007, Pages 682-693

  Vince, James E ^a   Wong, W Wei Lynn ^a   Khan, Nufail ^a   Feltham, Rebecca ^a   Chau, Diep ^a   Ahmed, Afsar U ^a   Benetatos, Christopher A ^b   Chunduru, Srinivas K ^b   Condon, Stephen M ^b   McKinlay, Mark ^b   Brink, Robert ^c   Leverkus, Martin ^d   Tergaonkar, Vinay ^e   Schneider, Pascal ^f   Callus, Bernard A ^a   Koentgen, Frank ^g   Vaux, David L ^a   Silke, John ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b TetraLogic Pharmaceuticals   (United States)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

^g Ozgene Pty Ltd   (Australia)

Author keywords

CELLBIO; HUMDISEASE; SIGNALING

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; BREFELDIN A; CASPASE 8 INHIBITOR; GELDANAMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER; CELL SURVIVAL; EMBRYO; GENE DELETION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; PROTEIN TARGETING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TUMOR; TUMOR CELL;

EID: 36148954336     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.10.037     Document Type: Article

References (35)

1. Bossen C., Ingold K., Tardivel A., Bodmer J.L., Gaide O., Hertig S., Ambrose C., Tschopp J., and Schneider P. Interactions of TNF and TNF receptor family members in the mouse and human. J. Biol. Chem. 281 (2006) 13964-13971
2. Broemer M., Krappmann D., and Scheidereit C. Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 23 (2004) 5378-5386
3. Chai J., Du C., Wu J.W., Kyin S., Wang X., and Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406 (2000) 855-862
4. Chen G., Cao P., and Goeddel D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell 9 (2002) 401-410
5. Conte D., Holcik M., Lefebvre C.A., Lacasse E., Picketts D.J., Wright K.E., and Korneluk R.G. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol. Cell. Biol. 26 (2006) 699-708
6. Conze D.B., Albert L., Ferrick D.A., Goeddel D.V., Yeh W.C., Mak T., and Ashwell J.D. Posttranscriptional Downregulation of c-IAP2 by the Ubiquitin Protein Ligase c-IAP1 In Vivo. Mol. Cell. Biol. 25 (2005) 3348-3356
7. Creagh E.M., Murphy B.M., Duriez P.J., Duckett C.S., and Martin S.J. Smac/Diablo antagonizes ubiquitin ligase activity of IAPs. J. Biol. Chem. 279 (2004) 26906-26914
8. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., Li Z.W., Karin M., Ware C.F., and Green D.R. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17 (2002) 525-535
9. Eckelman B.P., and Salvesen G.S. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 281 (2006) 3254-3260
10. Fotin-Mleczek M., Henkler F., Samel D., Reichwein M., Hausser A., Parmryd I., Scheurich P., Schmid J.A., and Wajant H. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J. Cell Sci. 115 (2002) 2757-2770
11. Grech A.P., Amesbury M., Chan T., Gardam S., Basten A., and Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21 (2004) 629-642
12. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., and Thompson C.B. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21 (2001) 3604-3608
13. He J.Q., Zarnegar B., Oganesyan G., Saha S.K., Yamazaki S., Doyle S.E., Dempsey P.W., and Cheng G. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J. Exp. Med. 203 (2006) 2413-2418
14. Hunter A.M., Lacasse E.C., and Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12 (2007) 1543-1568
15. Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., and Green D.R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1 (1998) 543-551
16. Li L., Thomas R.M., Suzuki H., De Brabander J.K., Wang X., and Harran P.G. A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death. Science 305 (2004) 1471-1474
17. Li X., Yang Y., and Ashwell J.D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416 (2002) 345-347
18. Nikolovska-Coleska Z., Wang R., Fang X., Pan H., Tomita Y., Li P., Roller P.P., Krajewski K., Saito N.G., Stuckey J.A., et al. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Anal. Biochem. 332 (2004) 261-273
19. Nowakowski G.S., McCollum A.K., Ames M.M., Mandrekar S.J., Reid J.M., Adjei A.A., Toft D.O., Safgren S.L., and Erlichman C. A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer. Clin. Cancer Res. 12 (2006) 6087-6093
20. Oost T.K., Sun C., Armstrong R.C., Al-Assaad A.S., Betz S.F., Deckwerth T.L., Ding H., Elmore S.W., Meadows R.P., Olejniczak E.T., et al. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J. Med. Chem. 47 (2004) 4417-4426
21. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., and Goeddel D.V. The TNF-R2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins. Cell 83 (1995) 1243-1252
22. Samuel T., Welsh K., Lober T., Togo S.H., Zapata J.M., and Reed J.C. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of TRAF2 and Smac. J. Biol. Chem. 281 (2006) 1080-1090
23. Schimmer A.D., Welsh K., Pinilla C., Wang Z., Krajewska M., Bonneau M.J., Pedersen I.M., Kitada S., Scott F.L., Bailly-Maitre B., et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5 (2004) 25-35
24. Senftleben U., Cao Y., Xiao G., Greten F.R., Krähn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293 (2001) 1495-1499
25. Shu H.B., Takeuchi M., and Goeddel D.V. The TNF-R2 signal transducers TRAF2 and c-IAP1 are components of the TNF-R1 signaling complex. Proc. Natl. Acad. Sci. USA 93 (1996) 13973-13978
26. Silke J., Kratina T., Ekert P.G., Pakusch M., and Vaux D.L. Unlike DIABLO/Smac, Grim promotes global ubiquitination and specific degradation of XIAP and neither cause apoptosis. J. Biol. Chem. 279 (2004) 4313-4321
27. Srinivasula S.M., Hegde R., Saleh A., Datta P., Shiozaki E., Chai J., Lee R.A., Robbins P.D., Fernandes-Alnemri T., Shi Y., et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410 (2001) 112-116
28. Tenev T., Zachariou A., Wilson R., Ditzel M., and Meier P. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat. Cell Biol. 7 (2005) 70-77
29. Uren A.G., Pakusch M., Hawkins C.J., Puls K.L., and Vaux D.L. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA 93 (1996) 4974-4978
30. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., and Verma I.M. Suppression of TNFα-induced apoptosis by NF-κB. Science 274 (1996) 787-789
31. Varfolomeev E., Wayson S.M., Dixit V.M., Fairbrother W.J., and Vucic D. The inhibitor of apoptosis protein fusion c-IAP2/MALT1 stimulates NF-κB activation independently of TRAF1 and TRAF2. J. Biol. Chem. 281 (2006) 29022-29029
32. Wang X., Ju W., Renouard J., Aden J., Belinsky S.A., and Lin Y. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res. 66 (2006) 1089-1095
33. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (2005) 1857-1861
34. Yang Q.H., and Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 279 (2004) 16963-16970
35. Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.T., Luk J.M., Wigler M., Hannon G.J., et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125 (2006) 1253-1267